Teladoc Health, Inc. (TDOC) Stock Price & Analysis
Teladoc Health, Inc. (TDOC) rose 1.27% to USD 8.77 as of July 25, 2026 at 01:44 UTC, according to Nexqual real-time market data.
TDOC last closed at USD 8.66; the session ranged USD 8.71–9 on volume of 4,345,443 shares. Market capitalization is $1.58B, with a 52-week range of USD 4.4–9.89 (NYQ). Source: Nexqual, July 25, 2026 at 01:44 UTC.
Key Statistics (as of July 25, 2026 at 01:44 UTC)
| Price | USD 8.77 |
|---|---|
| Change | ▲ 1.27% (up) |
| Previous Close | USD 8.66 |
| Open | USD 8.81 |
| Day Range | USD 8.71 – 9 |
| 52-Week Range | USD 4.4 – 9.89 |
| Volume | 4,345,443 shares |
| Market Cap | $1.58B |
| Exchange | NYQ |
Technical Analysis (TDOC)
Nexqual's technical model rates TDOC "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 01:44 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 50.83 (neutral) |
| vs SMA50 | Above (USD 7.97) |
| MACD | 0.33 (positive) |
Analyst Ratings (TDOC)
Wall Street analysts rate TDOC "Hold" based on 19 analysts, with a mean price target of USD 7.97 (range USD 5–11), per Nexqual as of July 25, 2026 at 01:44 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 19 |
| Mean Target | USD 7.97 |
| High Target | USD 11 |
| Low Target | USD 5 |
| Buy / Hold / Sell | 6 / 18 / 0 |
Earnings (TDOC)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD -0.23 |
| Revenue Estimate | $616.33M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.28 vs est -0.39 ▲ beat |
| 2025-12-31 | USD -0.1 vs est -0.22 ▲ beat |
| 2025-09-30 | USD -0.19 vs est -0.31 ▲ beat |
| 2025-06-30 | USD -0.15 vs est -0.31 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:44 UTC.
Financials & Fundamentals (TDOC)
| Total Revenue | $2.51B |
|---|---|
| Revenue Growth (YoY) | -2.50% |
| Gross Margin | +69.29% |
| Operating Margin | -7.94% |
| Profit Margin | -6.81% |
| ROE | -12.39% |
| Debt / Equity | 77.68 |
| Current Ratio | 2.8 |
| Total Cash | $750.74M |
| Total Debt | $1.04B |
| Free Cash Flow | $208.26M |
Source: Nexqual, July 25, 2026 at 01:44 UTC.
Financial Health Score (TDOC)
Nexqual rates Teladoc Health, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 01:44 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 69%, operating -8% |
| Balance Sheet | Mixed — $751M cash vs $1.04B debt |
| Cash Flow | Solid — FCF $208M, 8% margin |
| Efficiency | Critical — ROE -12%, ROA -3.1% |
Ownership (TDOC)
| Insider Ownership | +0.69% |
|---|---|
| Institutional Ownership | +83.69% |
| Shares Outstanding | 180.51M |
| Float | 179.34M |
| Short % of Float | +15.26% |
Source: Nexqual, July 25, 2026 at 01:44 UTC.
Leadership (TDOC)
Teladoc Health, Inc. is led by Charles Divita III (age 55), CEO, Interim Principal Financial Officer & Director, per Nexqual as of July 25, 2026 at 01:44 UTC.
| CEO, Interim Principal Financial Officer & Director | Charles Divita III (age 55) |
|---|---|
| President of International | Carlos Nueno (age 51) |
| President of U.S. Group Health | Kelly M. Bliss (age 50) |
| Chief Technology Officer | Dave Ross |
| Vice President of Investor Relations | Michael Minchak |
Major Backers & Investors (TDOC)
Notable institutional backers of Teladoc Health, Inc. include Renaissance Technologies, Point72 Asset Management, L.P., Voss Capital, LP, according to Nexqual as of July 25, 2026 at 01:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 4.48% |
| Point72 Asset Management, L.P. | 4.28% |
| Voss Capital, LP | 2.33% |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 2.09% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 19.61% |
| BlackRock | 10.45% |
| Dimensional Fund Advisors | 3.49% |
| Allianz Asset Management GmbH | 2.65% |
| State Street | 2.42% |
| Geode Capital | 2.32% |
Source: Nexqual, July 25, 2026 at 01:44 UTC.
From Teladoc Health, Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Key Strengths & Strategy (as disclosed to the SEC)
- Comprehensive Suite of Virtual Care Clinical Services We believe that we are the first and only company to offer a comprehensive and integrated virtual care solution that both provides and enables care for a full spectrum of clinical conditions, including wellness and prevention, acute care, chronic conditions, and complex healthcare needs.
- Integrated Care segment, we have ISO 9001 certification for key processes, as well as ISO 13485 and ISO 27001 certifications for our proprietary devices.
- Our BetterHelp segment primarily consists of our market leading mental health platform.
- Our platforms are compliant with numerous international data and privacy regulations, including the General Data Protection Regulation ("GDPR"), data-in-country rules, and other national requirements.
Partnerships
- THMG Association and Uplift Association We provide business support and administrative services pursuant to a services agreement with our affiliated clinical entities, including Teladoc Health Medical Group, P.A., formerly Teladoc Physicians, P.A. ("THMG") and Uplift Behavioral Health, P.C. ("Uplift PC"), which operate our Integrated Care and BetterHelp telehealth provider networks, respectively.
- These data sets and insights are applied to enhance the ability of providers to 7 Table of Contents deliver quality care through tools such as provider dashboards, as well as serving as a foundation for clinical innovation, and collaboration with other leading healthcare organizations that are focused on the advancement of virtual care delivery.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DOCU | DocuSign, Inc. | USD 50.44 | ▲ 5.32% |
| ZM | Zoom Communications, Inc. | USD 87.99 | ▲ 2.54% |
| XYZ | Block, Inc. | USD 77.15 | ▼ 0.4% |
| ROKU | Roku, Inc. | USD 141.97 | ▼ 0.78% |
| FSLY | Fastly, Inc. | USD 20.24 | ▼ 1.08% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:44 UTC. This page is informational and not investment advice.